IFN-α Sensitizes Human Umbilical Vein Endothelial Cells to Apoptosis Induced by Double-Stranded RNA

Journal of Immunology

Volumn 172, Issue 3, 2004, Pages 1699-1710

  Kaiser, William J ^a   Kaufman, Jonathan L ^a   Offermann, Margaret K ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; DOUBLE STRANDED RNA; INTERFERON REGULATORY FACTOR 3; PROTEIN KINASE; TOLL LIKE RECEPTOR 3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROGENY; SENSITIZATION; UMBILICAL VEIN; VIRION; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 1642525760     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.3.1699     Document Type: Article

References (99)

1. Castelli, J., K. A. Wood, and R. J. Youle. 1998. The 2-5A system in viral infection and apoptosis. Biomed. Pharmacother. 52:386.
2. Williams, B. R. 1999. PKR; a sentinel kinase for cellular stress. Oncogene 18:6112.
3. Williams, B. R., C. S. Gilbert, and I. M. Kerr. 1979. The respective roles of the protein kinase and pppA2′ p5′ A2′ p5 A-activated endonuclease in the inhibition of protein synthesis by double stranded RNA in rabbit reticulocyte lysates. Nucleic Acids Res. 6:1335.
4. Medzhitov, R., and C. Janeway, Jr. 2000. Innate immune recognition: mechanisms and pathways. Immunol. Rev. 173:89.
5. Au, W. C., P. A. Moore, W. Lowther, Y. T. Juang, and P. M. Pitha. 1995. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc. Natl. Acad. Sci. USA 92:11657.
6. Lin, R., C. Heylbroeck, P. M. Pitha, and J. Hiscott. 1998. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18:2986.
7. Weaver, B. K., K. P. Kumar, and N. C. Reich. 1998. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18:1359.
8. Visvanathan, K. V., and S. Goodbourn. 1989. Double-stranded RNA activates binding of NF-κB to an inducible element in the human β-interferon promoter. EMBO J. 8:1129.
9. Maniatis, T., J. V. Falvo, T. H. Kim, T. K. Kim, C. H. Lin, B. S. Parekh, and M. G. Wathelet. 1998. Structure and function of the interferon-β enhanceosome. Cold Spring Harbor Symp. Quant. Biol. 63:609.
10. Kalvakolanu, D., and E. C. Borden. 1996. An overview of the interferon system: signal transduction and mechanisms of action. Cancer Invest. 14:25.
11. Samuel, C. E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:778.
12. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413:732.
13. Miettinen, M., T. Sareneva, I. Julkunen, and S. Matikainen. 2001. IFNs activate Toll-like receptor gene expression in viral infections. Genes Immun. 2:349.
14. Friedman, H. M., E. J. Macarak, R. R. MacGregor, J. Wolfe, and N. A. Kefalides. 1981. Virus infection of endothelial cells. J. Infect. Dis. 143:266.
15. Harcourt, B., P. Rota, K. Hummel, W. Bellini, and M. Offermann. 1999. Induction of intercellular adhesion molecule 1 gene expression by measles virus in human umbilical vein endothelial cells. J. Med. Virol. 57:9.
16. Harcourt, B. H., A. Sanchez, and M. K. Offermann. 1999. Ebola virus selectively inhibits responses to interferons, but not to interleukin-1β, in endothelial cells. J. Virol. 73:3491.
17. Kahl, M., D. Siegel-Axel, S. Stenglein, G. Jahn, and C. Sinzger. 2000. Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains. J. Virol. 74:7628.
18. Schnittler, H. J., F. Mahner, D. Drenckhahn, H. D. Klenk, and H. Feldmann. 1993. Replication of Marburg virus in human endothelial cells: a possible mechanism for the development of viral hemorrhagic disease. J. Clin. Invest. 91:1301.
19. Harcourt, B. H., A. Sanchez, and M. K. Offerman. 1998. Ebola virus inhibits induction of genes by double-stranded RNA in endothelial cells. Virology 252:179.
20. Zaki, S. R., W.-J. Shich, P. W. Greer, C. S. Goldsmith, T. Ferebee, J. Katshitshi, F. K. Tshioko, M. A. Bwaka, T. Swanepoel, P. Calain, et al. 1999. A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. J. Infect. Dis. 179:S36.
21. Bosholl, C., T. F. Schulz, M. M. Kennedy, A. K. Graham, C. Fisher, A. Thomas, J. O. McGee, R. A. Weiss, and J. J. O'Leary. 1995. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat. Med. 1:1274.
22. Sturzl, M., C. Blasig, A. Schreier, F. Neipel, C. Hohenadl, E. Cornali, G. Ascherl, S. Esser, N. H. Brockmeyer, M. Ekman, et al. 1997. Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int. J. Cancer 72:68.
23. Borchers, A. T., R. Perez, G. Kaysen, A. A. Ansari, and M. E. Gershwin. 1999. Role of cytomegalovirus infection in allograft rejection: a review of possible mechanisms. Transplant Immunol. 7:75.
24. Fish, K. N., C. Soderberg-Naucler, L. K. Mills, S. Stenglein, and J. A. Nelson. 1998. Human cytomegalovirus persistently infects aortic endothelial cells. J. Virol. 72:5661.
25. Degre, M. 2002. Has cytomegalovirus infection any role in the development of atherosclerosis? Clin. Microbiol. Infect. 8:191.
26. Harcourt, J. L., M. K. Hagan, and M. K. Offermann. 2000. Modulation of double-stranded RNA-mediated gene induction by interferon in human umbilical vein endothelial cells. J. Interferon Cytokine Res. 20:1007.
27. Offermann, M. K., J. Zimring, K. H. Mellits, M. K. Hagan, R. Shaw, R. M. Medford, M. B. Mathews, S. Goodbourn, and R. Jagus. 1995. Activation of the double-stranded-RNA-activated protein kinase and induction of vascular cell adhesion molecule-1 by poly(I).poly(C) in endothelial cells. Eur. J. Biochem. 232:28.
28. Tailor, A., and D. N. Granger. 2000. Role of adhesion molecules in vascular regulation and damage. Curr. Hypertens. Rep. 2:78.
29. Alexander, J. S., J. W. Elrod, and J. H. Park. 2001. Roles of leukocyte and immune cell junctional proteins. Microcirculation 8:169.
30. Gromme, M., and J. Neefjes. 2002. Antigen degradation or presentation by MHC class 1 molecules via classical and non-classical pathways. Mol. Immunol. 39:181.
31. Klein, J., and A. Sato. 2000. The HLA system: first of two parts. N. Engl. J. Med. 343:702.
32. Garfinkel, S., D. S. Haines, S. Brown, J. Wessendorf, D. H. Gillespie, and T. Maciag. 1992. Interleukin-1α mediates an alternative pathway for the antiproliferative action of poly(I.C) on human endothelial cells. J. Biol. Chem. 267:24375.
33. Einhorn, S., A. Eldor, I. Vlodavsky, Z. Fuks, and A. Panet. 1985. Production and characterization of interferon from endothelial cells. J. Cell. Physiol. 122:200.
34. Strasser, A., L. O'Connor, and V. M. Dixit. 2000. Apoptosis signaling. Annu. Rev. Biochem. 69:217.
35. Benedict, C. A., P. S. Norris, and C. F. Ware. 2002. To kill or be killed: viral evasion of apoptosis. Nat. Immun. 3:1013.
36. Cuconati, A., and E. White. 2002. Viral homologs of bcl-2: role of apoptosis in the regulation of virus infection. Genes Dev. 16:2465.
37. Hardwick, J., and D. Bellows. 2003. Viral versus cellular bcl-2 proteins. Cell Death Differ. 10:S68.
38. Ameisen, J. C., O. Pleskoff, J. D. Lelievre, and F. De Bels. 2003. Subversion of cell survival and cell death: viruses as enemies, tools, teachers and allies. Cell Death Differ. 10:S3.
39. Gale, M., Jr., B. Kwieciszewski, M. Dossett, H. Nakao, and M. G. Katze. 1999. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J. Viral. 73:6506.
40. Barber, G. N. 2001. Host defense, viruses and apoptosis. Cell Death Differ. 8:113.
41. Hardwick, J. M. 2001. Apoptosis in viral pathogenesis. Cell Death Differ. 8:109.
42. Tschopp, J., M. Thome, K. Hofmann, and E. Meinl. 1998. The fight of viruses against apoptosis. Curr. Opin. Genet. Dev. 8:82.
43. Wang, J., J. D. Belcher, P. H. Marker, D. E. Wilcken, G. M. Vercellotti, and X. L. Wang. 2001. Cytomegalovirus inhibits p53 nuclear localization signal function. J. Mol. Med. 78:642.
44. Aguilar-Lemarroy, A., P. Gariglio, N. J. Whitaker, S. T. Eichhorst, H. zur Hausen, P. H. Krammer, and F. Rosl. 2002. Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis. Oncogene 21:165.
45. Filippova, M., H. Song, J. L. Connolly, T. S. Dermody, and P. J. Duerksen-Hughes. 2002. The human papillomavirus I6 E6 protein binds to tumor necrosis factor (TNF) RI and protects cells from TNF-induced apoptosis. J. Biol. Chem. 277:21730.
46. Friborg, J., Jr., W. Kong, M. O. Hottiger, and G. J. Nabel. 1999. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402:889.
47. Cheng, E. H., J. Nicholas, D. S. Bellows, G. S. Hayward, H. G. Guo, M. S. Reitz, and J. M. Hardwick. 1997. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc. Natl. Acad. Sci. USA 94:690.
48. Low, W., M. Harries, H. Ye, M. Q. Du, C. Boshoff, and M. Collins. 2001. Internal ribosome entry site regulates translation of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein. J. Virol. 75:2938.
49. Moore, P. S., and Y. Chang. 1998. Kaposi's sarcoma-associated herpesvirus-encoded oncogenes and oncogenesis. J. Natl. Cancer Inst. Monogr. 23:65.
50. Bannerman, D. D., J. C. Tupper, W. A. Ricketts, C. F. Bennett, R. K. Winn, and J. M. Harlan. 2001. A constitutive cytoprotective pathway protects endothelial cells from lipopolysaccharide-induced apoptosis. J. Biol. Chem. 276:14924.
51. Sata, M., and K. Walsh. 1998. Endothelial cell apoptosis induced by oxidized LDL is associated with the down-regulation of the cellular caspase inhibitor FLIP. J. Biol. Chem. 273:33103.
52. Adams, M. D., M. Dubnick, A. R. Kerlavage, R. Moreno, J. M. Kelley, T. R. Utterback, J. W. Nagle, C. Fields, and J. C. Venter. 1992. Sequence identification of 2.375 human brain genes. Nature 355:632.
53. Justesen, J., R. Hartmann, and N. O. Kjeldgaard. 2000. Gene structure and function of the 2′-5′-oligoadenylate synthetase family. Cell. Mol. Life Sci. 57:1593.
54. Tan, S. L., and M. G. Katze. 1999. The emerging role of the interferon-induced PKR protein kinase as an apoptotic effector: a new face of death? J. Interferon Cytokine Res. 19:543.
55. Turpaev, K., R. Hartmann, and J. Justesen. 1999. 2′-Adenylated derivatives of Ap3A activate RNase L. FEBS Lett. 457:9.
56. Jiang, Z., M. Zamanian-Daryoush, H. Nie, A. M. Silva, and X. Li. 2003. Poly I:C-induced TLR-3-mediated activation of NF-κB and MAP kinases is through an IRAK-independent pathway employing components TLR3-TRAF6-TAK-1-TAB2-PKR. J. Biol. Chem. 27:27.
57. Kumar-Sinha, C., S. Varambally, A. Sreekumar, and A. M. Chinnaiyan. 2002. Molecular cross-talk between the TRAIL and interferon signaling pathways. J. Biol. Chem. 277:575.
58. Vidalain, P. O., O. Azocar, H. Yagita, C. Rabourdin-Combe, and C. Servet-Delprat. 2001. Cytotoxic activity of human dendritic cells is differentially regulated by double-stranded RNA and CD40 ligand. J. Immunol. 167:3765.
59. Vattern, K. M., K. A. Staschke, and R. C. Wek. 2001. Mechanism of activation of the double-stranded-RNA-dependent protein kinase. PKR: role of dimerization and cellular localization in the stimulation of PKR phosphorylation of eukaryotic initiation factor-2 (eIF2). Eur. J. Biochem. 268:3674.
60. Desai, S. Y., and G. C. Sen. 1997. Effects of varying lengths of double-stranded RNA on binding and activation of 2′-5′ -oligoadenylate synthetase. J. Interferon Cytokine Res. 17:531.
61. Gribaudo, G., D. Lembo, G. Cavallo, S. Landolfo, and P. Lengyel. 1991. Interferon action: binding of viral RNA to the 40-kilodalton 2′-5′-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. J. Virol. 65:1748.
62. Hengartner, M. O. 2000. The biochemistry of apoptosis. Nature 407:770.
63. Konopleva, M., S. Zhao, Z. Xie, H. Segall, A. Younes, D. F. Claxton, Z. Estrov, S. M. Kornblau, and M. Andreeff. 1999. Apoptosis: molecules and mechanisms. Adv. Exp. Med. Biol. 457:217.
64. Donepudi, M., and M. G. Grutter. 2002. Structure and zymogen activation of caspases. Biophys. Chem. 101:145.
65. Stennicke, H. R., M. Renatus, M. Meldal, and G. S. Salvesen. 2000. Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8. Biochem. J. 350:563.
66. Thornberry, N. A., T. A. Rano, E. P. Peterson, D. M. Rasper, T. Timkey, M. Garcia-Calvo, V. M. Houtzager, P. A. Nordstrom, S. Roy. J. P. Vaillancourt, et al. 1997. A combinatorial approach defines specificities of members of the caspase family and granzyme B: functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272:17907.
67. Chen, D., R. A. Stetler, G. Cao, W. Pei, C. O'Horo, X. M. Yin, and J. Chen. 2000. Characterization of the rat DNA fragmentation factor 35/inhibitor of caspase-activated DNase (short form): the endogenous inhibitor of caspase-dependent DNA fragmentation in neuronal apoptosis. J. Biol Chem. 275:38508.
68. Gu, J., R. P. Dong, C. Zhang, D. F. McLaughlin, M. X. Wu, and S. F. Schlossman. 1999. Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40. J. Biol. Chem. 274:20759.
69. Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10:417.
70. Kuida, K., J. A. Lippke, G. Ku, M. W. Harding, D. J. Livingston, M. S. Su, and R. A. Flavell. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267:2000.
71. Thornberry, N. A., H. G. Bull, J. R. Calaycay, K. T. Chapman, A. D. Howard, M. J. Kostura, D. K. Miller, S. M. Molineaux, J. R. Weidner, J. Aunins, et al. 1992. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356:768.
72. Janicke, R. U., P. Ng, M. L. Sprengart, and A. G. Porter. 1998. Caspase-3 is required for α-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J. Biol. Chem. 273:15540.
73. Li, S., Y. Zhao, X. He, T. H. Kim, D. K. Kuharsky, H. Rabinowich, J. Chen, C. Du, and X. M. Yin. 2002. Relief of extrinsic pathway inhibition by the Bid-dependent mitochondrial release of Smac in Fas-mediated hepatocyte apoptosis. J. Biol. Chem. 277:26912.
74. Tafani, M., N. O. Karpinich, K. A. Hurster, J. G. Pastorino, T. Schneider, M. A. Russo, and J. L. Farber. 2002. Cytochrome c release upon Fas receptor activation depends on translocation of full-length bid and the induction of the mitochondrial permeability transition. J. Biol. Chem. 277:10073.
75. Drexler, H. C., W. Risau, and M. A. Konerding. 2000. Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells. FASEB J. 14:65.
76. Chen, Z., J. Hagler, V. J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9:1586.
77. Palombella, V. J., O. J. Rando, A. L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773.
78. Sears, C., J. Olesen, D. Rubin, D. Finley, and T. Maniatis. 1998. NF-κB p105 processing via the ubiquitin-proteasome pathway. J. Biol. Chem. 273:1409.
79. Li, X. L., and B. A. Hassel. 2001. Involvement of proteasomes in gene induction by interferon and double-stranded RNA. Cytokine 14:247.
80. Katze, M. G., Y. He, and M. Gale. Jr. 2002. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2:675.
81. Slowik, M. R., W. Min, T. Ardito, A. Karsan, M. Kasligarian, and J. S. Pober. 1997. Evidence that tumor necrosis factor triggers apoptosis in human endothelial cells by interleukin-1-converting enzyme-like protease-dependent and -independent pathways. Lab. Invest. 77:257.
82. Rebouillat, D., and A. G. Hovanessian. 1999. The human 2′, 5′-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. J. Interferon Cytokine Res. 19:295.
83. Hovanessian, A. G. 1991. Interferon-induced and double-stranded RNA-activated enzymes: a specific protein kinase and 2′, 5′-oligoadenylate synthetases. J. Interferon Res. 11:199.
84. Fitzgerald, K., S. McWhirter, K. Faia, D. Rowe, E. ZLatz, D. Golenbock, A. Coyle, S.-M. Liao, and T. Maniatis. 2003. IKKe and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immun. 4:491.
85. Rehm, M., H. Dussmann, R. U. Janicke, J. M. Tavare, D. Kogel, and J. H. Prehn. 2002. Single-cell fluorescence resonance energy transfer analysis demonstrates that caspase activation during apoptosis is a rapid process: role of caspase-3. J. Biol. Chem. 277:24506.
86. Luo, X., I. Budihardjo, H. Zou, C. Slaughter, and X. Wang. 1998. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481.
87. Bernardi, P., V. Petronilli, F. Di Lisa, and M. Forte. 2001. A mitochondrial perspective on cell death. Trends Biochem. Sci. 26:112.
88. Shi, Y. 2002. Mechanism of caspase activation and inhibition during apoptosis. Mol. Cell 9:459.
89. Gil, J., J. Alcami, and M. Esteban. 1999. Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the α subunit of eukaryotic translation initiation factor 2 and NF-′B. Mol. Cell. Biol. 19:4653.
90. Zhou, A., J. Paranjape, T. L. Brown, H. Nie, S. Naik, B. Dong, A. Chang, B. Trapp, R. Fairchild, C. Colmenares, and R. H. Silverman. 1997. Interferon action and apoptosis are defective in mice devoid of 2′, 5′-oligoadenylate-dependent RNase L. EMBO J. 16:6355.
91. De Haro, C., R. Mendez, and J. Santoyo. 1996. The eIF-2α kinases and the control of protein synthesis. FASEB J. 10:1378.
92. Player, M. R., and P. F. Torrence. 1998. The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation. Pharmacol. Ther. 78:55.
93. Saelens, X., M. Kalai, and P. Vandenabeele. 2001. Translation inhibition in apoptosis: caspase-dependent PKR activation and elF2-α phosphorylation. J. Biol. Chem. 276:41620.
94. Stehlik, C., R. de Martin, I. Kumabashiri, J. A. Schmid, B. R. Binder, and J. Lipp. 1998. Nuclear factor (NF)-κB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis. J. Exp. Med. 188:211.
95. Micheau, O., S. Lens, O. Gaide, K. Alevizopoulos, and J. Tschopp. 2001. NF-κB signals induce the expression of c-FLIP. Mol. Cell. Biol. 21:5299.
96. MacFarlane, M., W. Merrison, S. B. Bratton, and G. M. Cohen. 2002. Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro. J. Biol. Chem. 16:16.
97. Huang, H., C. A. Joazeiro, E. Bonfoco, S. Kamada, J. D. Leverson, and T. Hunter. 2000. The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J. Biol. Chem. 275:26661.
98. Suzuki, Y., Y. Nakabayashi, and R. Takahashi. 2001. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc. Natl. Acad. Sci. USA 98:8662.
99. Balachandran, S., P. C. Roberts, L. E. Brown, H. Truong, A. K. Pattnaik, D. R. Archer, and G. N. Barber. 2000. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13:129.